Pfizer Inc. v. Teva Pharmaceuticals Usa, Inc.

U.S. Court of Appeals for the Federal Circuit

Pfizer Inc. v. Teva Pharmaceuticals Usa, Inc.

Opinion

Case: 12-1576 Document: 70 Page: 1 Filed: 10/17/2012

NOTE: This order is nonprecedential.

mtntteb ~tates <!Court of ~peaIs for tbe jfeberaI <!Ctreutt

PFIZER INC., WARNER-LAMBERT COMPANYLLC, AND C.P. PHARMACEUTICALS INTERNATIONAL C.V., Plaintiffs-Appellees,

AND NORTHWESTERN UNIVERSITY, Plaintiff-Appellee,

v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellants,

AND LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants,

AND

ACTAVIS, INC. AND ACTAVIS ELIZABETH, LLC, Defendants-Appellants,

AND COBALT LABORATORIES, INC. AND COBALT PHARMACEUTICALS, INC., Defendants-Appellants, Case: 12-1576 Document: 70 Page: 2 Filed: 10/17/2012

PFIZER INC. V. TEVA PHARMACEUTICALS USA 2

AND

SUN PHARMA GLOBAL, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, INC., Defendants-Appellants,

AND

WOCKHARDT LIMITED AND WOCKHARDT USA, LLC, Defendants-Appellants,

AND

ALPHAPHARM PTY. LTD. AND MYLAN PHARMACEUTICALS, INC., Defendants-Appellants.

2012-1576, -1601, -1602, -1603, -1604, -1605, -1607

Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0307, Chief Judge Gregory M. Sleet.

ON MOTION

ORDER The parties jointly move for an extension of 31 days, until November 19, 2012, for the appellants to file their principal briefs and 46 days, until February 15, 2013, for appellees to file their responsive brief. Case: 12-1576 Document: 70 Page: 3 Filed: 10/17/2012

PFIZER INC. V. TEVA PHARMACEUTICALS USA 3

Upon consideration thereof,

IT Is ORDERED THAT:

The motion is granted.

FOR THE COURT

/s/ Jan Horbaly Jan Horbaly Clerk s27

Reference

Status
Unpublished